Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01380886 · ClinicalTrials.gov registry record · Phase 3
Growth and Tolerance of Young Infants Fed Infant Formulas
A Phase 3 study, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 3
- Development phase
- 209
- Enrollment target
NCT01380886: Completed Phase 3 study, sponsored by Abbott Nutrition.
NCT01380886 is a Phase 3 study that has completed, run by Abbott Nutrition. The registered enrollment target is 209 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01380886, a Phase 3 study, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 209 participants
- Enrollment target
Study Summary
This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
Interventions
- OTHER experimental infant formula with alternate protein source
- OTHER Infant formula powder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2011-06 |
| Est. Completion | 2011-12 |
| Phase | Phase 3 |
What the finished NCT01380886 record still lists
NCT01380886 is an interventional study that assigns participants to a tested intervention. The registered 209 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which experimental infant formula with alternate protein source is the first listed.
NCT01380886 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01380886 about?
NCT01380886 is a clinical study titled "Growth and Tolerance of Young Infants Fed Infant Formulas". This is a randomized, multi-center, double blind, parallel study to compare growth and tolerance of healthy term infants fed either control or experimental infant formula.
What is the current status of trial NCT01380886?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 209 participants. The study started on 2011-06. Estimated completion is 2011-12.
What interventions are being tested in trial NCT01380886?
The interventions under investigation include: experimental infant formula with alternate protein source (OTHER), Infant formula powder (OTHER).
Who is sponsoring clinical trial NCT01380886?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01380886's enrollment target sits among peer trials
209 1345th of 2000 higher than 656 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04742634 · 209 participants · Phase 1
Pre-emptive Therapy With DEC-C to Improve Outcomes in MDS Patients With Measurable Residual Disease Post Allogeneic Hematopoietic Cell Transplant
- NCT07214688 · 209 participants · Phase 2
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia